Literature DB >> 12839935

Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer.

Takeshi Tomonaga1, Kazuyuki Matsushita, Seiko Yamaguchi, Tatsuya Oohashi, Hideaki Shimada, Takenori Ochiai, Kinya Yoda, Fumio Nomura.   

Abstract

Aneuploidy is the hallmark of many human cancers. Recent work has strongly suggested that chromosome missegregation during mitosis is the main cause of aneuploidy and contributes to oncogenesis. Centromere protein (CENP)-A is the centromere-specific histone-H3-like variant essential for centromere structure and function. It plays a central role in the assembly of the protein complex, termed kinetochore, which is indispensable for equal chromosome segregation. In this study, we demonstrate that the kinetochore protein CENP-A was overexpressed in all of 11 primary human colorectal cancer tissues. CENP-A mRNA was also up-regulated, indicating that overexpression of CENP-A occurred at the transcriptional level. Immunostaining with anti-CENP-A antibodies showed increased CENP-A signals in the tumor cells. Moreover, coimmunostaining of CENP-B, a centromere-associated DNA binding protein, with CENP-A showed mistargeting of CENP-A to noncentromeric chromatin in the tumor cells. These results suggest that overexpression of CENP-A could play an important role for aneuploidy in colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12839935

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  142 in total

Review 1.  Pericentric and centromeric transcription: a perfect balance required.

Authors:  Laura E Hall; Sarah E Mitchell; Rachel J O'Neill
Journal:  Chromosome Res       Date:  2012-07       Impact factor: 5.239

Review 2.  Centromere identity: a challenge to be faced.

Authors:  Gunjan D Mehta; Meenakshi P Agarwal; Santanu Kumar Ghosh
Journal:  Mol Genet Genomics       Date:  2010-06-29       Impact factor: 3.291

Review 3.  Neocentromeres and epigenetically inherited features of centromeres.

Authors:  Laura S Burrack; Judith Berman
Journal:  Chromosome Res       Date:  2012-07       Impact factor: 5.239

4.  Psh1 is an E3 ubiquitin ligase that targets the centromeric histone variant Cse4.

Authors:  Geetha Hewawasam; Manjunatha Shivaraju; Mark Mattingly; Swaminathan Venkatesh; Skylar Martin-Brown; Laurence Florens; Jerry L Workman; Jennifer L Gerton
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

5.  An E3 ubiquitin ligase prevents ectopic localization of the centromeric histone H3 variant via the centromere targeting domain.

Authors:  Prerana Ranjitkar; Maximilian O Press; Xianhua Yi; Richard Baker; Michael J MacCoss; Sue Biggins
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

Review 6.  Putting CENP-A in its place.

Authors:  Madison E Stellfox; Aaron O Bailey; Daniel R Foltz
Journal:  Cell Mol Life Sci       Date:  2012-06-23       Impact factor: 9.261

Review 7.  No longer a nuisance: long non-coding RNAs join CENP-A in epigenetic centromere regulation.

Authors:  Silvana Rošić; Sylvia Erhardt
Journal:  Cell Mol Life Sci       Date:  2016-01-09       Impact factor: 9.261

Review 8.  The right place at the right time: chaperoning core histone variants.

Authors:  Francesca Mattiroli; Sheena D'Arcy; Karolin Luger
Journal:  EMBO Rep       Date:  2015-10-12       Impact factor: 8.807

9.  The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.

Authors:  Rocío Montes de Oca; Zachary A Gurard-Levin; Frédérique Berger; Haniya Rehman; Elise Martel; Armelle Corpet; Leanne de Koning; Isabelle Vassias; Laurence O W Wilson; Didier Meseure; Fabien Reyal; Alexia Savignoni; Bernard Asselain; Xavier Sastre-Garau; Geneviève Almouzni
Journal:  Mol Oncol       Date:  2014-11-20       Impact factor: 6.603

10.  Altered dosage and mislocalization of histone H3 and Cse4p lead to chromosome loss in Saccharomyces cerevisiae.

Authors:  Wei-Chun Au; Matthew J Crisp; Steven Z DeLuca; Oliver J Rando; Munira A Basrai
Journal:  Genetics       Date:  2008-05-05       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.